{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:41:52Z","timestamp":1776901312337,"version":"3.51.2"},"publisher-location":"New York, NY","reference-count":27,"publisher":"Springer US","isbn-type":[{"value":"9781071651971","type":"print"},{"value":"9781071651988","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5198-8_15","type":"book-chapter","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:03:45Z","timestamp":1776899025000},"page":"209-224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Applications of Fundus-Tracked Perimetry in the Assessment of Visual Sensitivity"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1101-2870","authenticated-orcid":false,"given":"Alexis Ceecee","family":"Britten-Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janise","family":"Dagelet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren N.","family":"Ayton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"3","key":"15_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.oret.2020.07.019","volume":"5","author":"M Sa\u00dfmannshausen","year":"2021","unstructured":"Sa\u00dfmannshausen M, Zhou J, Pfau M, Thiele S, Steinberg J, Fleckenstein M, Holz FG, Schmitz-Valckenberg S (2021) Longitudinal analysis of retinal thickness and retinal function in eyes with large Drusen secondary to intermediate age-related macular degeneration. Ophthalmol Retina 5(3):241\u2013250. https:\/\/doi.org\/10.1016\/j.oret.2020.07.019","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"15_CR2","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.oret.2019.07.008","volume":"3","author":"Z Wu","year":"2019","unstructured":"Wu Z, Luu CD, Hodgson LAB, Caruso E, Brassington KH, Tindill N, Aung KZ, Harper CA, Wickremasinghe SS, Sandhu SS, McGuinness MB, Chen FK, Chakravarthy U, Arnold JJ, Heriot WJ, Durkin SR, Wintergerst MWM, Gorgi Zadeh S, Schultz T, Finger RP, Cohn AC, Baglin EK, Sharangan P, Guymer RH (2019) Secondary and exploratory outcomes of the subthreshold nanosecond laser intervention randomized trial in age-related macular degeneration: a LEAD study report. Ophthalmol Retina 3(12):1026\u20131034. https:\/\/doi.org\/10.1016\/j.oret.2019.07.008","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"15_CR3","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1007\/s00417-021-05277-y","volume":"259","author":"A Boned-Murillo","year":"2021","unstructured":"Boned-Murillo A, Diaz-Barreda MD, Ferreras A, Bartolom\u00e9-Ses\u00e9 I, Orduna-Hospital E, Montes-Rodr\u00edguez P, Ascaso J, Pinilla I (2021) Structural and functional findings in patients with moderate diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 259(12):3625\u20133635. https:\/\/doi.org\/10.1007\/s00417-021-05277-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"15_CR4","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1167\/iovs.05-1141","volume":"47","author":"S Vujosevic","year":"2006","unstructured":"Vujosevic S, Midena E, Pilotto E, Radin PP, Chiesa L, Cavarzeran F (2006) Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings. Invest Ophthalmol Vis Sci 47(7):3044\u20133051. https:\/\/doi.org\/10.1167\/iovs.05-1141","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"15_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/bjo.2009.159772","volume":"94","author":"VC Lima","year":"2010","unstructured":"Lima VC, Prata TS, Moraes CGVD, Kim J, Seiple W, Rosen RB, Liebmann JM, Ritch R (2010) A comparison between microperimetry and standard achromatic perimetry of the central visual field in eyes with glaucomatous paracentral visual-field defects. Br J Ophthalmol 94(1):64. https:\/\/doi.org\/10.1136\/bjo.2009.159772","journal-title":"Br J Ophthalmol"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2017.12.002","volume":"187","author":"M Matsuura","year":"2018","unstructured":"Matsuura M, Murata H, Fujino Y, Hirasawa K, Yanagisawa M, Asaoka R (2018) Evaluating the usefulness of MP-3 microperimetry in glaucoma patients. Am J Ophthalmol 187:1\u20139. https:\/\/doi.org\/10.1016\/j.ajo.2017.12.002","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"15_CR7","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/ceo.14110","volume":"50","author":"AC Britten-Jones","year":"2022","unstructured":"Britten-Jones AC, O'Hare F, Edwards TL, Ayton LN (2022) Victorian evolution of inherited retinal diseases natural history registry (VENTURE study): rationale, methodology, and initial participant characteristics. Clin Experiment Ophthalmol 50(7):768\u2013780. https:\/\/doi.org\/10.1111\/ceo.14110","journal-title":"Clin Experiment Ophthalmol"},{"key":"15_CR8","doi-asserted-by":"publisher","unstructured":"Nguyen XT, Talib M, van Schooneveld MJ, Wijnholds J, van Genderen MM, Schalij-Delfos NE, Klaver CCW, Talsma HE, Fiocco M, Florijn RJ, Ten Brink JB, Cremers FPM, Meester-Smoor MA, Ingeborgh van den Born L, Hoyng CB, Thiadens A, Bergen AA, Boon CJF (2021) CRB1-associated retinal dystrophies: a prospective natural history study in anticipation of future clinical trials. Am J Ophthalmol. https:\/\/doi.org\/10.1016\/j.ajo.2021.07.021","DOI":"10.1016\/j.ajo.2021.07.021"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ajo.2022.08.013","volume":"244","author":"EM Lad","year":"2022","unstructured":"Lad EM, Duncan JL, Liang W, Maguire MG, Ayala AR, Audo I, Birch DG, Carroll J, Cheetham JK, Durham TA, Fahim AT, Loo J, Deng Z, Mukherjee D, Heon E, Hufnagel RB, Guan B, Iannaccone A, Jaffe GJ, Kay CN, Michaelides M, Pennesi ME, Vincent A, Weng CY, Farsiu S (2022) Baseline microperimetry and OCT in the RUSH2A study: structure-function association and correlation with disease severity. Am J Ophthalmol 244:98\u2013116. https:\/\/doi.org\/10.1016\/j.ajo.2022.08.013","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"15_CR10","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.gim.2021.10.013","volume":"24","author":"AC Britten-Jones","year":"2021","unstructured":"Britten-Jones AC, Jin R, Gocuk SA, Cichello E, O\u2019Hare F, Hickey DG, Edwards TL, Ayton LN (2021) The safety and efficacy of gene therapy treatment for monogenic retinal and optic nerve diseases: a systematic review. Genet Med 24(3):521\u2013534. https:\/\/doi.org\/10.1016\/j.gim.2021.10.013","journal-title":"Genet Med"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/jamaophthalmol.2019.3278","volume":"29","author":"MD Fischer","year":"2019","unstructured":"Fischer MD, Ochakovski GA, Beier B, Seitz IP, Vaheb Y, Kortuem C, Reichel FFL, Kuehlewein L, Kahle NA, Peters T, Girach A, Zrenner E, Ueffing M, MacLaren RE, Bartz-Schmidt KU, Wilhelm B (2019) Efficacy and safety of retinal gene therapy using adeno-associated virus vector for patients with choroideremia: a randomized clinical trial. JAMA Ophthalmol 29:29. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.3278","journal-title":"JAMA Ophthalmol"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ajo.2018.09.012","volume":"197","author":"BL Lam","year":"2019","unstructured":"Lam BL, Davis JL, Gregori NZ, MacLaren RE, Girach A, Verriotto JD, Rodriguez B, Rosa PR, Zhang X, Feuer WJ (2019) Choroideremia gene therapy phase 2 clinical trial: 24-month results. Am J Ophthalmol 197:65\u201373. https:\/\/doi.org\/10.1016\/j.ajo.2018.09.012","journal-title":"Am J Ophthalmol"},{"issue":"9923","key":"15_CR13","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0140-6736(13)62117-0","volume":"383","author":"RE MacLaren","year":"2014","unstructured":"MacLaren RE, Groppe M, Barnard AR, Cottriall CL, Tolmachova T, Seymour L, Clark KR, During MJ, Cremers FP, Black GC, Lotery AJ, Downes SM, Webster AR, Seabra MC (2014) Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial. Lancet 383(9923):1129\u20131137. https:\/\/doi.org\/10.1016\/S0140-6736(13)62117-0","journal-title":"Lancet"},{"issue":"3","key":"15_CR14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41591-020-0763-1","volume":"26","author":"J Cehajic-Kapetanovic","year":"2020","unstructured":"Cehajic-Kapetanovic J, Xue K, Martinez-Fernandez de la Camara C, Nanda A, Davies A, Wood LJ, Salvetti AP, Fischer MD, Aylward JW, Barnard AR, Jolly JK, Luo E, Lujan BJ, Ong T, Girach A, Black GCM, Gregori NZ, Davis JL, Rosa PR, Lotery AJ, Lam BL, Stanga PE, MacLaren RE (2020) Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR. Nat Med 26(3):354\u2013359. https:\/\/doi.org\/10.1038\/s41591-020-0763-1","journal-title":"Nat Med"},{"issue":"6","key":"15_CR15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1001\/jamaophthalmol.2020.1032","volume":"138","author":"MD Fischer","year":"2020","unstructured":"Fischer MD, Michalakis S, Wilhelm B, Zobor D, Muehlfriedel R, Kohl S, Weisschuh N, Ochakovski GA, Klein R, Schoen C, Sothilingam V, Garcia-Garrido M, Kuehlewein L, Kahle N, Werner A, Dauletbekov D, Paquet-Durand F, Tsang S, Martus P, Peters T, Seeliger M, Bartz-Schmidt KU, Ueffing M, Zrenner E, Biel M, Wissinger B (2020) Safety and vision outcomes of subretinal gene therapy targeting cone photoreceptors in achromatopsia: a nonrandomized controlled trial. JAMA Ophthalmol 138(6):643\u2013651. https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.1032","journal-title":"JAMA Ophthalmol"},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ajo.2018.06.011","volume":"193","author":"IS Dimopoulos","year":"2018","unstructured":"Dimopoulos IS, Hoang SC, Radziwon A, Binczyk NM, Seabra MC, MacLaren RE, Somani R, Tennant MTS, MacDonald IM (2018) Two-year results after AAV2-mediated gene therapy for choroideremia: the Alberta experience. Am J Ophthalmol 193:130\u2013142. https:\/\/doi.org\/10.1016\/j.ajo.2018.06.011","journal-title":"Am J Ophthalmol"},{"issue":"20","key":"15_CR17","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","volume":"372","author":"JWB Bainbridge","year":"2015","unstructured":"Bainbridge JWB, Mehat MS, Sundaram V, Robbie SJ, Barker SE, Ripamonti C, Georgiadis A, Mowat FM, Beattie SG, Gardner PJ, Feathers KL, Luong VA, Yzer S, Balaggan K, Viswanathan A, De Ravel TJL, Casteels I, Holder GE, Tyler N, Fitzke FW, Weleber RG, Nardini M, Moore AT, Thompson DA, Petersen-Jones SM, Michaelides M, Van Den Born LI, Stockman A, Smith AJ, Rubin G, Ali RR (2015) Long-term effect of gene therapy on Leber's congenital amaurosis. New Eng J Med 372(20):1887\u20131897. https:\/\/doi.org\/10.1056\/NEJMoa1414221","journal-title":"New Eng J Med"},{"issue":"1","key":"15_CR18","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ymthe.2017.09.014","volume":"26","author":"G Le Meur","year":"2018","unstructured":"Le Meur G, Lebranchu P, Billaud F, Adjali O, Schmitt S, Bezieau S, Pereon Y, Valabregue R, Ivan C, Darmon C, Moullier P, Rolling F, Weber M (2018) Safety and long-term efficacy of AAV4 gene therapy in patients with RPE65 leber congenital amaurosis. Mol Ther 26(1):256\u2013268. https:\/\/doi.org\/10.1016\/j.ymthe.2017.09.014","journal-title":"Mol Ther"},{"issue":"9","key":"15_CR19","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.ymthe.2018.05.025","volume":"26","author":"C Cukras","year":"2018","unstructured":"Cukras C, Wiley HE, Jeffrey BG, Sen HN, Turriff A, Zeng Y, Vijayasarathy C, Marangoni D, Ziccardi L, Kjellstrom S, Park TK, Hiriyanna S, Wright JF, Colosi P, Wu Z, Bush RA, Wei LL, Sieving PA (2018) Retinal AAV8-RS1 gene therapy for X-linked retinoschisis: initial findings from a phase I\/IIa trial by Intravitreal delivery. Mol Ther 26(9):2282\u20132294. https:\/\/doi.org\/10.1016\/j.ymthe.2018.05.025","journal-title":"Mol Ther"},{"issue":"1","key":"15_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/bjophthalmol-2017-310258","volume":"102","author":"S Balasubramanian","year":"2018","unstructured":"Balasubramanian S, Uji A, Lei J, Velaga S, Nittala M, Sadda S (2018) Interdevice comparison of retinal sensitivity assessments in a healthy population: the CenterVue MAIA and the Nidek MP-3 microperimeters. Br J Ophthalmol 102(1):109\u2013113. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310258","journal-title":"Br J Ophthalmol"},{"key":"15_CR21","doi-asserted-by":"publisher","unstructured":"Pfau M, Jolly JK, Wu Z, Denniss J, Lad EM, Guymer RH, Fleckenstein M, Holz FG, Schmitz-Valckenberg S (2020) Fundus-controlled perimetry (microperimetry): application as outcome measure in clinical trials. Prog Retin Eye Res:100907. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100907","DOI":"10.1016\/j.preteyeres.2020.100907"},{"issue":"1","key":"15_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/IAE.0000000000002360","volume":"40","author":"MD Fischer","year":"2020","unstructured":"Fischer MD, Ochakovski GA, Beier B, Seitz IP, Vaheb Y, Kortuem C, Reichel FFL, Kuehlewein L, Kahle NA, Peters T, Girach A, Zrenner E, Ueffing M, MacLaren RE, Bartz-Schmidt K, Wilhelm B (2020) Changes in retinal sensitivity after gene therapy in choroideremia. Retina 40(1):160\u2013168. https:\/\/doi.org\/10.1097\/IAE.0000000000002360","journal-title":"Retina"},{"issue":"7","key":"15_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/tvst.10.7.12","volume":"10","author":"AS Josan","year":"2021","unstructured":"Josan AS, Buckley TMW, Wood LJ, Jolly JK, Cehajic-Kapetanovic J, MacLaren RE (2021) Microperimetry hill of vision and volumetric measures of retinal sensitivity. Transl Vis Sci Technol 10(7):12. https:\/\/doi.org\/10.1167\/tvst.10.7.12","journal-title":"Transl Vis Sci Technol"},{"issue":"12","key":"15_CR24","doi-asserted-by":"publisher","first-page":"7378","DOI":"10.1167\/iovs.13-12617","volume":"54","author":"Z Wu","year":"2013","unstructured":"Wu Z, Ayton LN, Guymer RH, Luu CD (2013) Intrasession test-retest variability of microperimetry in age-related macular degeneration. Invest Ophthalmol Vis Sci 54(12):7378\u20137385. https:\/\/doi.org\/10.1167\/iovs.13-12617","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"15_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1167\/tvst.12.5.21","volume":"12","author":"AS Josan","year":"2023","unstructured":"Josan AS, Farrance I, Taylor LJ, Adeyoju D, Buckley TMW, Jolly JK, MacLaren RE (2023) Microperimetry reliability assessed from fixation performance. Transl Vis Sci Technol 12(5):21. https:\/\/doi.org\/10.1167\/tvst.12.5.21","journal-title":"Transl Vis Sci Technol"},{"issue":"5","key":"15_CR26","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/ceo.12907","volume":"45","author":"RC Han","year":"2017","unstructured":"Han RC, Jolly JK, Xue K, MacLaren RE (2017) Effects of pupil dilation on MAIA microperimetry. Clin Experiment Ophthalmol 45(5):489\u2013495. https:\/\/doi.org\/10.1111\/ceo.12907","journal-title":"Clin Experiment Ophthalmol"},{"issue":"8","key":"15_CR27","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1136\/bjophthalmol-2018-312253","volume":"103","author":"RC Han","year":"2019","unstructured":"Han RC, Gray JM, Han J, Maclaren RE, Jolly JK (2019) Optimisation of dark adaptation time required for mesopic microperimetry. Br J Ophthalmol 103(8):1092\u20131098. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-312253","journal-title":"Br J Ophthalmol"}],"container-title":["Methods in Molecular Biology","Retinal Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5198-8_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:03:46Z","timestamp":1776899026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5198-8_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071651971","9781071651988"],"references-count":27,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5198-8_15","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 April 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}